Curis prices ~$8.5M private placement of 16.7M units with $0.60 warrants
AI Summary
Curis announced a private placement of 16,666,680 common shares (or pre-funded warrants in lieu) plus common warrants to purchase up to 16,666,680 shares at a combined effective price of $0.51 per unit, expected to raise approximately $8.5M before fees. The common warrants carry a $0.60 exercise price, are exercisable six months after issuance (expire 5.5 years after issuance), and pre-funded warrants have a $0.01 exercise price and are exercisable immediately; the offering is expected to close on or about October 19, 2026. The company also agreed to amend existing warrants (1,126,676 January-2026 warrants and 3,733,334 August-2026 warrants) to a reduced $0.60 exercise price, creating additional potential future dilution of up to 4,860,010 shares. Timing: The press release does not indicate dilution today. Earliest dilution: Oct 19, 2026 settlement. Earliest dilution: Oct 19, 2026 settlement.
Positives
- Gross proceeds expected to be ~ $8.5M before fees
- Company says proceeds should fund operations through initial CLL data in 5–10 patients (expected Dec 2026)
Negatives
- Large warrant component: one common warrant per unit exercisable at $0.60 starting six months post-issuance (potential +16.7M shares later)
- Pre-funded warrants exercisable immediately (holders using pre-funded warrants can cause immediate share dilution at closing)
- Company amended existing warrants (totaling 4,860,010 shares) to $0.60 exercise price, increasing near-term exercise incentive
Filing Context
Filing and Dilution Context
Earliest dilution
Earliest dilution: Oct 19, 2026 settlement
Dilution status
delayed
Dilution timing
Dilution status: Delayed
Trigger type
settlement
Trigger date
Oct 19, 2026